E-LIB Suche - Ergebnisse für: Bakker, Marina

1

Infliximab use in the Netherlands: Uptake and characteristi..:

Overbeek, Jetty A. ; Kuiper, Josephina G. ; Bakker, Marina..
British Journal of Clinical Pharmacology. 88 (2021) 4 - p. 1804-1810 , 2021

Link: https://doi.org/10.1111/..

2

PHARMO Database Network:

, In: Databases for Pharmacoepidemiological Research; Springer Series on Epidemiology and Public Health,

Bakker, Marina ; Herings, Ron - p. 109-118 , 2021

Link: https://doi.org/10.1007/..

3

Existing Data Sources for Clinical Epidemiology: The PHARMO..:

Kuiper, Josephina G ; Bakker, Marina ; Penning-van Beest, Fernie JA.
Clinical Epidemiology. 12 (2020) - p. 415-422 , 2020

Link: https://doi.org/10.2147/..

4

Introducing new vaccines in low- and middle-income countrie..:

Guignard, Adrienne ; Praet, Nicolas ; Jusot, Viviane..
Expert Review of Vaccines. 18 (2019) 2 - p. 119-131 , 2019

Link: https://doi.org/10.1080/..

5

Risk of dipeptidyl peptidase‐4 (DPP‐4) inhibitors on site‐s..:

Overbeek, Jetty A. ; Bakker, Marina ; van der Heijden, Amber A.W.A....
Diabetes/Metabolism Research and Reviews. 34 (2018) 5 - p. , 2018

Link: https://doi.org/10.1002/..

6

The incidence, clearance and persistence of non-cervical hu..:

Taylor, Sylvia ; Bunge, Eveline ; Bakker, Marina.
BMC Infectious Diseases. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

7

Immunogenicity, effectiveness and safety of combined hepati..:

Bakker, Marina ; Bunge, Eveline M. ; Marano, Cinzia..
Expert Review of Vaccines. 15 (2016) 7 - p. 829-851 , 2016

Link: https://doi.org/10.1586/..

8

Selective decontamination of the digestive tract and select..:

Oostdijk, Evelien A N ; de Wit, G A ; Bakker, Marina..
BMJ Open. 3 (2013) 3 - p. e002529 , 2013

Link: https://doi.org/10.1136/..

9

Added value of CAC in risk stratification for cardiovascula..:

Peters, Sanne A. E. ; Bakker, Marina ; den Ruijter, Hester M..
European Journal of Clinical Investigation. 42 (2011) 1 - p. 110-116 , 2011

Link: https://doi.org/10.1111/..

10

Existing Data Sources for Clinical Epidemiology: The PHARMO..:

Kuiper, Josephina G ; Bakker, Marina ; Penning-van Beest, Fernie J A.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196787/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Existing Data Sources for Clinical Epidemiology: The PHARMO..:

Kuiper, Josephina G ; Bakker, Marina ; Penning-van Beest, Fernie JA.
info:eu-repo/semantics/altIdentifier/doi/10.2147/CLEP.S247575. , 2020

Link: https://www.dovepress.co..

12

The incidence, clearance and persistence of non-cervical hu..:

Taylor, Sylvia ; Bunge, Eveline ; Bakker, Marina.
Reproducció del document publicat a: https://doi.org/10.1186/s12879-016-1633-9. , 2016

Link: http://hdl.handle.net/24..

13

The incidence, clearance and persistence of non-cervical hu..:

Taylor, Sylvia ; Bunge, Eveline ; Bakker, Marina.
http://www.biomedcentral.com/1471-2334/16/293. , 2016

Link: http://www.biomedcentral..

14

Selective decontamination of the digestive tract and select..:

Oostdijk, Evelien A N ; de Wit, G A ; Bakker, Marina..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612803. , 2013

Link: http://www.ncbi.nlm.nih...

15

Selective decontamination of the digestive tract and select..:

Oostdijk, Evelien A. N ; de Wit, G. A ; Bakker, Marina..
https://research.rug.nl/en/publications/f1166365-bc03-4940-8da2-0e9406ae1990. , 2013

Link: https://hdl.handle.net/1..